Our Pricing

Your Complete Guide to Creatine And Mounjaro

Published on: June 03, 2026

Many UK patients ask whether creatine and mounjaro uk can be safely combined during their weight loss journey. As a UK-registered pharmacy with extensive experience supporting tirzepatide patients, we've created this evidence-based guide to help you understand the interaction between creatine supplementation and Mounjaro treatment. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team regularly advise patients on supplement safety during prescription weight loss therapy.

Can You Take Creatine With Mounjaro?

There is currently no documented pharmacological interaction between creatine monohydrate and tirzepatide (Mounjaro's active ingredient). Creatine is a naturally occurring compound that supports muscle energy metabolism, whilst Mounjaro is a dual GIP/GLP-1 receptor agonist that regulates appetite and blood sugar [1]. These substances work through entirely different biological pathways and do not compete for absorption or metabolism.

However, combining creatine and Mounjaro requires careful consideration of several clinical factors. During significant weight loss—such as the average 15-22.5% body weight reduction observed in the SURPASS clinical trials—maintaining lean muscle mass becomes crucial [1][2]. Creatine supplementation may help preserve muscle tissue when combined with resistance training, potentially supporting better body composition outcomes during tirzepatide therapy.

That said, both substances affect fluid balance and kidney function in different ways. Mounjaro can cause dehydration through gastrointestinal side effects, whilst creatine increases intracellular water retention in muscle tissue. UK prescribers typically recommend ensuring adequate hydration (2-3 litres daily) if combining these treatments, and monitoring kidney function through routine blood tests.

Understanding Mounjaro (Tirzepatide) for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway medications such as semaglutide (Wegovy), tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced metabolic effects.

In the landmark SURPASS-3 trial, patients receiving the 15mg maintenance dose achieved an average 22.5% total body weight reduction over 72 weeks—significantly greater than comparator treatments [1]. The medication works by slowing gastric emptying, reducing appetite, improving insulin sensitivity, and increasing energy expenditure. Clinical trials demonstrated that approximately 63% of patients achieved at least 20% weight loss on the highest dose [2].

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. UK prescribers typically initiate treatment at 2.5mg weekly, gradually escalating the dose every 4 weeks to minimise gastrointestinal side effects. The medication requires ongoing clinical supervision and is prescribed alongside a reduced-calorie diet and increased physical activity programme.

Who Can Be Prescribed Mounjaro in the UK

MHRA-approved prescribing criteria require adults to have a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea. All patients require clinical assessment by a UK-registered prescriber before treatment initiation, including review of medical history, current medications, and contraindications such as personal or family history of medullary thyroid carcinoma.

What Is Creatine and Why Do People Take It?

Creatine monohydrate is one of the most extensively researched nutritional supplements, with over 1,000 published studies demonstrating its safety and efficacy for improving exercise performance and supporting muscle mass [3]. Approximately 95% of the body's creatine is stored in skeletal muscle, where it rapidly regenerates adenosine triphosphate (ATP)—the primary energy currency for high-intensity muscular contractions.

Supplementation typically involves a loading phase (20g daily for 5-7 days) followed by a maintenance dose of 3-5g daily, though many individuals skip loading and use maintenance dosing from the outset. Clinical research consistently shows creatine supplementation increases lean body mass, improves strength and power output, and may help preserve muscle tissue during caloric restriction [3][4].

For patients undergoing significant weight loss with Mounjaro, preserving lean muscle mass is essential for maintaining metabolic rate and functional capacity. Research indicates that approximately 20-30% of weight lost during caloric restriction comes from lean tissue rather than fat mass. Combining resistance training with creatine supplementation may help mitigate this muscle loss, though this approach requires adequate protein intake (1.6-2.2g per kilogram body weight daily) and progressive strength training.

Creatine's Effect on Body Weight and Composition

It's important to understand that creatine typically causes an initial 1-2kg weight increase due to increased intracellular water retention in muscle tissue [3]. This can be psychologically challenging for patients focused on the number displayed on scales during Mounjaro treatment. However, this water weight represents improved muscle hydration rather than fat gain, and does not interfere with Mounjaro's fat-reducing mechanisms. Body composition analysis (such as DEXA scanning or bioelectrical impedance) provides more meaningful data than scale weight alone when combining these interventions.

Creatine And Mounjaro UK: Key Safety Considerations

Whilst there are no direct pharmacological interactions between creatine and tirzepatide, several clinical considerations warrant attention when combining these substances. The most significant concern relates to kidney function monitoring. Creatine supplementation increases serum creatinine levels—a metabolic byproduct used as a marker of kidney function—by approximately 10-20% even in individuals with healthy kidneys [4]. This elevation reflects increased creatine metabolism rather than kidney damage, but it can complicate interpretation of routine blood tests.

Mounjaro itself does not directly impair kidney function, but severe dehydration from gastrointestinal side effects (nausea, vomiting, diarrhoea) can cause acute kidney injury in susceptible individuals. UK prescribers typically recommend baseline kidney function testing (serum creatinine and estimated glomerular filtration rate) before initiating Mounjaro, with repeat testing if concerning symptoms develop. If you're taking creatine, inform your prescriber so they can interpret results appropriately.

Hydration becomes doubly important when combining these treatments. Aim for at least 2-3 litres of water daily, increasing intake during hot weather or intense exercise. Signs of inadequate hydration include dark urine, dizziness upon standing, persistent headaches, and reduced urination frequency. If you experience severe or persistent vomiting or diarrhoea whilst on Mounjaro, temporarily discontinue creatine supplementation and contact your healthcare provider.

Optimising Muscle Preservation During Mounjaro Treatment

Clinical experience with GLP-1 receptor agonists demonstrates that rapid weight loss without targeted muscle preservation strategies often results in significant lean tissue loss. A comprehensive approach to maintaining muscle mass during Mounjaro treatment includes adequate protein intake, progressive resistance training, and potentially creatine supplementation as an adjunct [4].

UK nutrition guidelines for individuals undergoing medical weight loss recommend protein intake of 1.6-2.2g per kilogram of ideal body weight daily, distributed across 3-4 meals. This elevated protein target—significantly higher than standard recommendations—provides amino acids necessary for muscle protein synthesis even during caloric deficit. Combining high protein intake with resistance training 2-3 times weekly creates the optimal environment for muscle preservation.

Creatine supplementation may enhance the effectiveness of resistance training during weight loss by improving workout performance and supporting muscle recovery. A standard maintenance dose of 3-5g daily, taken at any time of day with or without food, is sufficient for most individuals. Some patients prefer taking creatine with carbohydrate-containing meals to potentially enhance muscle uptake, though this timing consideration is less important than consistent daily supplementation.

Monitoring Your Progress Beyond Scale Weight

When combining creatine with Mounjaro, tracking body composition rather than total body weight provides more meaningful data. Consider measuring waist circumference monthly, taking progress photographs in consistent lighting and positions, and monitoring strength progression in the gym. Many UK patients find that whilst scale weight may plateau temporarily after starting creatine, measurements continue decreasing and body composition visibly improves—reflecting ongoing fat loss despite stable or slightly increased muscle mass and hydration.

Alternative Weight Loss Treatments Available at Cured Pharmacy

Whilst Mounjaro represents the most effective pharmacological option currently available for weight loss, several alternative treatments suit different patient needs and circumstances. Wegovy (semaglutide) is a once-weekly injectable GLP-1 receptor agonist that achieved average weight loss of 15% over 68 weeks in the STEP clinical trials [5]. As a single-pathway medication, it typically produces slightly less weight reduction than Mounjaro but remains highly effective for many patients.

Saxenda (liraglutide) offers another injectable option with daily administration rather than weekly dosing. Some patients prefer the daily routine and greater dosing flexibility, whilst others find weekly injections more convenient. For patients who prefer oral medications, Orlistat and Xenical work through fat malabsorption rather than appetite suppression, blocking approximately 30% of dietary fat absorption. These treatments require adherence to a reduced-fat diet to minimise gastrointestinal side effects.

All prescription weight loss medications available through Cured Pharmacy require clinical assessment by a UK-registered prescriber. Our online consultation process takes under 3 minutes and includes comprehensive review of your medical history, current medications, and weight loss goals. Pricing is transparent and displayed upfront—Mounjaro starts from £124.99, with final cost determined by your prescribed dose and treatment duration. Our clinical team provides ongoing support throughout your weight loss journey, with regular check-ins to monitor progress and adjust treatment as needed.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Ludvik, B., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
3. Kreider, R. B., et al. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 14, 18. https://doi.org/10.1186/s12970-017-0173-z [accessed 13 August 2026]
4. Forbes, S. C., et al. (2021). Effects of Creatine Supplementation on Brain Function and Health. Nutrients, 14(5), 921. https://doi.org/10.3390/nu14050921 [accessed 13 August 2026]
5. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or supplement regimen. Creatine supplementation should be discussed with your prescriber, particularly if you have existing kidney conditions or are taking medications that affect kidney function.